CEO, Koti Meka As CFO
Oct 6 (Reuters) - Qualigen Therapeutics Inc QLGN.O: QUALIGEN THERAPEUTICS (NASDAQ: QLGN) ANNOUNCES EXECUTIVES, BOARD OF DIRECTORS APPOINTMENTS AND AUDITOR TRANSITION QUALIGEN THERAPEUTICS INC - JERRY WANG APPOINTED AS CO-CEO, KOTI MEKA AS CFO Source text: ID:nGNX5kcS75 Further company coverage: QLGN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aixcrypto Holdings
See all newsBrief: Aixcrypto - Enters Common Shares Purchase Agreement With Gold King Arthur Holding - SEC Filing
Chief Executive Officer And Director
Brief: Aixcrypto Holdings - Enters Note Purchase Agreement With CABG Acquisition Corp On May 12, 2026 - SEC Filing
Brief: Aixcrypto Holdings Reports First Quarter 2026 Results
AIxCrypto Q1 net loss widens as expenses rise